Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 5 of 5 citing Esposito: Addition of neutral protamine lispro insulin or insulin glargine to oral type 2.... (0.05 sec) 

[CITATION] Insulin therapy in type 2 diabetes mellitus


NPOFI SECRETION, I PREPARATIONS, C …
Related articles

Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared …


… , LA Morrow, AP Kollmeier, BN Campaigne, … - Current Medical Research & Opinion, 2009 - informahealthcare.com
The primary aim was to evaluate duration of action of a single 0.8 U/kg dose of
insulin lispro protamine suspension (ILPS) in type 2 diabetes (T2DM) patients;
secondarily to compare onset and duration of action of ILPS, glargine (G), ...
Related articles - All 4 versions

Insulin lispro protamine suspension in intensive insulin treatment: an Italian observational …


G Citro, B Lorusso, A Rossi, M Romaniello, R … - Current Medical Research and Opinion, 2009 - informahealthcare.com
Results: The mean duration of therapy was 229.3 days. Total insulin daily dosage
did not change statistically in the observation period. FPG and HbA 1c levels
decreased significantly (p < 0.001) in this period, with no increase in ...
Related articles - All 5 versions

Contact frequency determines outcome of basal insulin initiation trials in type 2 diabetes

- nih.gov
SGHA Swinnen, JH DeVries - Diabetologia, 2009 - Springer
Abstract Aims/hypothesis The aim of the present study was to investigate whether
predetermined contact frequency with the study team and endpoint insulin dose
are associated with study outcomes in basal insulin initiation trials in ...
Related articles - All 3 versions

[CITATION] Last literature review version 17.1: Thu Jan 01 00: 00: 00 GMT 2009| This topic last …


… SECRETION, I PREPARATIONS, C DRUG, I …
Related articles - All 2 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google